0001209191-17-002284.txt : 20170105 0001209191-17-002284.hdr.sgml : 20170105 20170105175458 ACCESSION NUMBER: 0001209191-17-002284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170103 FILED AS OF DATE: 20170105 DATE AS OF CHANGE: 20170105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Halstead Michael CENTRAL INDEX KEY: 0001521548 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36274 FILM NUMBER: 17512143 MAIL ADDRESS: STREET 1: C/O WARNER CHILCOTT CORPORATION STREET 2: 100 ENTERPRISE DRIVE CITY: ROCKAWAY STATE: NJ ZIP: 07866 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-03 0 0001567514 Intra-Cellular Therapies, Inc. ITCI 0001521548 Halstead Michael C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET NEW YORK NY 10016 0 1 0 0 SVP and General Counsel Common Stock 2017-01-04 4 M 0 3107 A 23107 D Stock Option (right to buy) 15.73 2017-01-03 4 A 0 63717 0.00 A 2027-01-03 Common Stock 63717 63717 D Restricted Stock Units 2017-01-03 4 A 0 15893 0.00 A Common Stock 15893 15893 D Restricted Stock Units 2017-01-04 4 M 0 3107 0.00 D Common Stock 3107 6216 D Restricted stock units convert into common stock on a one-for-one basis. On January 3, 2017, the reporting person was granted options to purchase 63,717 shares of common stock, vesting in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of common stock. On January 3, 2017, the reporting person was granted 15,893 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. On January 4, 2016, the reporting person was granted 9,323 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. /s/ Lawrence J. Hineline, Attorney-in-fact 2017-01-05